UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027644
Receipt number R000031672
Scientific Title A study for the effect of intake of ingredients derived from animal on cognitive functions
Date of disclosure of the study information 2018/12/30
Last modified on 2017/12/05 11:25:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for the effect of intake of ingredients derived from animal on cognitive functions

Acronym

A study for the effect of intake of ingredients derived from animal on cognitive functions

Scientific Title

A study for the effect of intake of ingredients derived from animal on cognitive functions

Scientific Title:Acronym

A study for the effect of intake of ingredients derived from animal on cognitive functions

Region

Japan


Condition

Condition

None (Healthy adults)

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of intake of ingredients derived from animal on cognitive functions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Tests for memory functions

Key secondary outcomes

Tests for memory functions
Tests for attention functions
Tests for executive functions
Tests for mental status
Questionnaires


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of food containing ingredients derived from animal, 6 tablets a day, 12 weeks

Interventions/Control_2

Intake of placebo 6 tablets a day, 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Men and women aged from 45 to 64
2)Subjects whose primary language is Japanese
3)Subjects with self-awareness of forgetfulness, especially who often forget the name of people, or objects
4)Subjects who often carelessly make mistakes in daily life
5)Subjects with inferior scores of primary outcome

Key exclusion criteria

1)Subjects who have difficulties in recognition of colors
2)Subjects whose visual or hearing acuity is too low to perform tests, or who have been diagnosed as amblyopia, blindness, or deafness
3)Subjects whose score of the HDS-R is less than 20
4)Subjects who have anamnesis of cranial nerve disease
5)Subjects who have depressive symptoms, or who have been diagnosed as depressive disorder
6)Subjects who are being treated with hormone, or who have been diagnosed as menopausal symptoms
7)Subjects who sometimes have irregular lifestyles during the study
8)Heavy drinkers
9)Smokers or subjects who started smoking cessation within 12 months
10)Subjects who have taken the similar cognitive function tests within 12 months
11)Subjects who are being treated for cognitive functions, or who are prescribed drugs associated with cognitive functions
12)Subjects who regularly take drugs or health foods which may affect cognitive functions more than once a week
13)Subjects who regularly take foods similar to test foods more than once a week
14)Subjects who regularly take energy drinks more than once a week
15)Subjects who have done blood transfusion or blood donation within 3 months
16)Subjects who have participated in other clinical studies within 1 month, or who are planning to participate in other clinical studies during this study
17)Subjects who have diseases requiring regular administration, or who have severe diseases
18)Subjects who are judged as unsuitable by doctor for laboratory value, anthropometric measurements, or physical examination value
19)Subjects who may have physical deconditioning due to test foods
20)Subjects who are, or are planning to be pregnant or breastfeeding during study
21)Subjects who are judged as unsuitable due to lifestyle questionnaire
22)Subjects who and whose family work in a company developing functional foods
23)Subjects who are judged as unsuitable by doctor for other reasons

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kuniaki Obara

Organization

Kirin company, Limited

Division name

Research and Development division, Research Laboratories for Health Science & Food Technologies

Zip code


Address

1-13-5, Fukuura Kanazawa-ku, Yokohama, Japan

TEL

080-1930-9932

Email

k-obara@kirin.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takashi Nakagawa

Organization

TTC Co.,Ltd.

Division name

Clinical Research Planning Department

Zip code


Address

Seibu Shinkin Bank Ebisu Bldg., 1-20-2, Ebisunishi, Shibuya-ku, Tokyo

TEL

03-5459-5329

Homepage URL


Email

t.nakagawa@ttc-tokyo.co.jp


Sponsor or person

Institute

TTC Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

Kirin company, Limited

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 05 Month 16 Day

Date of IRB


Anticipated trial start date

2017 Year 06 Month 15 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 05 Day

Last modified on

2017 Year 12 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031672


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name